Short answer
MESA LABORATORIES INC /CO/ (MLAB) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $61M with net income of $2M.
Q3 2025 key financials · XBRL
- Revenue
- $61M
- +2.0% QoQ
- Net income
- $2M
- −47.8% QoQ
- Operating margin
- 7.8%
- Gross margin
- 61.5%
- EPS (diluted)
- $0.45
- −47.1% QoQ
Source: XBRL data from the MESA LABORATORIES INC /CO/ (MLAB) Q3 2025 10-Q on SEC EDGAR. USD.
MESA LABORATORIES INC /CO/ Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Six-month revenue growth 3.7% YoY, driven by Calibration Solutions, BPD, and Sterilization and Disinfection Control
- Gross margin 61.7% vs prior-year period, down 1.0 percentage point
- Clinical Genomics worst performer, with China revenue declines from trade tensions and macroeconomic weakness
- Sterilization and Disinfection Control historically most profitable division, receiving $0.9M reinvestment
- Annualized cost reductions approximately $2.3M beginning fiscal Q3 2026, with China headwinds expected through fiscal 2027
Risk Factors
- No material risk-factor changes provided from the March 31, 2025 Form 10-K
- Carried-forward risks unavailable because the excerpt contains no substantive Risk Factors text
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other MESA LABORATORIES INC /CO/ quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.